Delivery Order SPE2DR25D1104-SPE2DR26FK287
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,633.07 to AmerisourceBergen Drug Corp for Prilosec DR 2.5 mg suspension (30 count) on September 17, 2025, with a completion date of September 18, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product, with a ceiling value of $4,235.30 and a period of performance through May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,685.17, is for the provision of Prilosec DR 10 mg suspension medication to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Prilosec DR 10 mg suspension. The $4,261.76 firm fixed-price contract has an ultimate completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,594.28 for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 31, 2024, with a completion date of February 1, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg suspension. The $4,689.52 firm fixed price contract has a completion date of July 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is for the delivery of Prilosec DR 2.5 mg suspension 30s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,105.68, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 2.5 mg suspension, a medical product, with a ceiling value of $1,974.48 and a period of performance through November 16, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,205.36, is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a prescription medication. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK287Delivery Order
The Defense Logistics Agency awarded a $2,097.10 delivery order to AmerisourceBergen Drug Corp for PRILOSEC DR 10 mg suspension (30-count) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed price, non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is part of AmerisourceBergen's comprehensive pharmaceutical supply arrangement with the Defense Logistics Agency, through which the company provides a broad range of medications and medical supplies supporting military healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains extensive product capabilities across multiple therapeutic domains and serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's IDC with DLA Troop Support Medical functions as a global pharmaceutical support vehicle enabling flexible delivery of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/7/25 |